---
input_text: Cryotolerance of Sperm from Transgenic Rhesus Macaques (Macaca mulatta).
  Cryopreservation is an important tool routinely used in preserving sperm for assisted
  reproductive technologies and for genetic preservation of unique animal models.
  Here we investigated the viability of fresh and frozen sperm from rhesus macaques
  on the basis of motility, membrane integrity, and acrosome integrity. Sperm motility
  was determined by visual evaluation; membrane and acrosome integrity were assessed
  simultaneously through triple staining with Hoechst 33342, propidium iodide, and
  fluorescein isothiocyanate-peanut agglutinin. We compared thawed semen that had
  been cryopreserved by using 2 different media with fresh semen from wildtype (WT)
  macaques; fresh semen from a model of Huntington disease (HD) with fresh WT semen;
  and fresh HD with cryopreserved-thawed HD semen. Our new freezing media (TEST EQ)
  preserved the acrosome better, with less net damage, than did traditional TEST (egg
  yolk extender containing TES and Tris) media. In addition, the percentage of membrane-damaged
  cells was similar in fresh HD semen (38.6%+-2.9%) and WT semen (35.5%+-1.9%). Membrane
  and acrosomal damage were not different between HD and WT sperm after cryopreservation
  and subsequent thawing. Furthermore, cryopreservation had similar negative effects
  on the motility of HD and WT sperm. These data illustrate that semen from a rhesus
  macaque model of HD is similarly cryotoleratant to that from WT animals.
raw_completion_output: |-
  primary_disease: Huntington disease
  medical_actions: Cryopreservation;visual evaluation;triple staining with Hoechst 33342, propidium iodide, and fluorescein isothiocyanate-peanut agglutinin
  symptoms: Membrane damage;Acrosomal damage;Decreased motility
  chemicals: Hoechst 33342;propidium iodide;fluorescein isothiocyanate-peanut agglutinin;TES;Tris
  action_annotation_relationships: Cryopreservation (with TEST EQ) PREVENTS Acrosomal damage IN Huntington disease;visual evaluation TREATS Decreased motility IN Huntington disease;triple staining with Hoechst 33342, propidium iodide, and fluorescein isothiocyanate-peanut agglutinin TREATS Membrane damage IN Huntington disease;Cryopreservation PREVENTS Membrane damage IN Huntington disease;Cryopreservation PREVENTS Decreased motility IN Huntington disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Cryopreservation PREVENTS Decreased motility IN Huntington disease

  ===

extracted_object:
  primary_disease: MONDO:0007739
  medical_actions:
    - Cryopreservation
    - visual evaluation
    - triple staining with Hoechst 33342, propidium iodide, and fluorescein isothiocyanate-peanut
      agglutinin
  symptoms:
    - Membrane damage
    - Acrosomal damage
    - Decreased motility
  chemicals:
    - CHEBI:51232
    - CHEBI:51240
    - fluorescein isothiocyanate-peanut agglutinin
    - CHEBI:30452
    - CHEBI:9754
  action_annotation_relationships:
    - subject: Cryopreservation
      predicate: PREVENTS
      object: Acrosomal damage
      qualifier: MONDO:0007739
      subject_qualifier: with TEST EQ
      subject_extension: TEST EQ
    - subject: visual evaluation
      predicate: TREATS
      object: Decreased motility
      qualifier: MONDO:0007739
    - subject: triple staining
      predicate: TREATS
      object: Membrane damage
      qualifier: MONDO:0007739
      subject_extension: Hoechst 33342, propidium iodide, and fluorescein isothiocyanate-peanut
        agglutinin
    - subject: Cryopreservation
      predicate: PREVENTS
      object: Membrane damage
      qualifier: MONDO:0007739
    - subject: Cryopreservation
      predicate: PREVENTS
      object: Decreased motility
      qualifier: MONDO:0007739
named_entities:
  - id: MONDO:0005559
    label: Neurodegeneration
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0000708
    label: Behavioral changes
  - id: CHEBI:64645
    label: Beta-amyloid
  - id: CHEBI:36355
    label: Tau
  - id: MONDO:0002602
    label: Central Nervous System Diseases
  - id: HP:0000618
    label: Blindness
  - id: HP:0001658
    label: Myocardial infarction
  - id: MONDO:0007739
    label: Huntington disease
  - id: MAXO:0009017
    label: cognitive tests
  - id: HP:0001268
    label: cognitive decline
  - id: MONDO:0020074
    label: Progressive Myoclonic Epilepsy (PME)
  - id: MAXO:0000932
    label: Electroencephalography (EEG) studies
  - id: HP:0025464
    label: oxidative stress
  - id: CHEBI:16610
    label: Spermidine
  - id: CHEBI:16348
    label: 3-nitropropionic acid (3-NP)
  - id: CHEBI:16856
    label: Glutathione (GSH)
  - id: CHEBI:16301
    label: Nitrite
  - id: CHEBI:63895
    label: Interleukin (IL)-6
  - id: CHEBI:16865
    label: Gamma-aminobutyric acid (GABA)
  - id: CHEBI:29987
    label: Glutamate
  - id: CHEBI:17256
    label: Dopamine (DA)
  - id: CHEBI:33310
    label: Norepinephrine (NE)
  - id: CHEBI:28790
    label: 5-HT
  - id: CHEBI:41941
    label: 3,4-dihydroxyphenylacetic acid (DOPAC)
  - id: CHEBI:545959
    label: Homovanillic acid (HVA)
  - id: CHEBI:27823
    label: 5-hydroxyindoleacetic acid (5-HIAA)
  - id: CHEBI:16335
    label: Adenosine
  - id: CHEBI:17596
    label: Inosine
  - id: CHEBI:17368
    label: Hypoxanthine
  - id: HP:0003202
    label: muscle wasting
  - id: MAXO:0000127
    label: Genetic testing
  - id: MAXO:0000137
    label: PET scan
  - id: MONDO:0019260
    label: Adult Neuronal Ceroid Lipofuscinosis (ANCL)
  - id: CHEBI:53018
    label: dinitrophenol (DNP)
  - id: CHEBI:25675
    label: oligomycin
  - id: HP:0004305
    label: Involuntary movements
  - id: HP:0002072
    label: chorea
  - id: HP:0001824
    label: weight loss
  - id: CHEBI:27314
    label: water-soluble vitamins
  - id: CHEBI:46662
    label: minerals
  - id: MAXO:0000610
    label: Enzyme-linked immunosorbent assay
  - id: HP:0000739
    label: Anxiety
  - id: HP:0000716
    label: Depression
  - id: MONDO:0010997
    label: Progressive supranuclear palsy (PSP)
  - id: HP:0000605
    label: Supranuclear gaze palsy (SGP)
  - id: MONDO:0005180
    label: Parkinson disease
  - id: CHEBI:134738
    label: Laquinimod
  - id: HP:0012743
    label: abdominal obesity
  - id: CHEBI:28240
    label: Dichloroacetate
  - id: CHEBI:46024
    label: Trichostatin A
  - id: CHEBI:30513
    label: Sodium butyrate (SB)
  - id: CHEBI:75316
    label: Sodium phenylbutyrate
  - id: CHEBI:64103
    label: Sodium butyrate
  - id: CHEBI:51232
    label: Hoechst 33342
  - id: CHEBI:51240
    label: propidium iodide
  - id: CHEBI:30452
    label: TES
  - id: CHEBI:9754
    label: Tris
